NOVOSEVEN
5MG(250KIU) INJ PSO LQF 1+1X5ML III
| SÚKL code | 0194242 |
|---|---|
| Name of the product | NOVOSEVEN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | NOVOSEVEN |
| Supplement | 5MG(250KIU) INJ PSO LQF 1+1X5ML III |
| Strenght | 5MG(250KIU) |
| Pharmaceutical form | Powder and solvent for solution for injection |
| Package | 1+1X5ML III |
| Route | Intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | EPTACOG ALFA (ACTIVATED) (EPTACOGUM ALFA (ACTIVATUM)) |
| ATC group | B02BD08 |
| ATC group name | KOAGULAČNÍ FAKTOR VIIA |
| Doping | Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | EU/1/96/006/010 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Novo Nordisk A/S, Bagsvaerd |
| MA Holder country | DÁNSKO |
cz